Hologic Inc. HOLX Breast Health segment is likely to have witnessed strong performance owing to increased sales of its interventional breast solutions products driven by Brevera systems and related ...

Hologic’s HOLX progress in the domestic and international markets, a strong pipeline of products and continued solid performance of the Molecular Diagnostics segment bolster our confidence. The stock ...

Hologic, Inc. HOLX recently announced the addition of improved features to its Brevera Breast Biopsy System with CorLumina Imaging Technology. Notably, the system was launched in 2017 and has been ...

Hologic’s HOLX $18.3 billion private takeover deal by Blackstone and TPG is progressing toward completion. Announced in October 2025 after months of market speculation, the transaction is said to ...